Vincent Rajkumar
@VincentRK
Followers
80K
Following
64K
Media
4K
Statuses
53K
Editor-in-Chief, Blood Cancer Journal; Chairman @IMFmyeloma Board; Cancer & Myeloma Research; Opinions solely personal views https://t.co/HOGYJSpsoG
Rochester, MN, USA
Joined March 2009
I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives. 1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.
146
1K
5K
RT @MikkaelSekeres: My favorite time of year…when @VincentRK and I get to share a stage and give educational talks for the @GWtweets re….
0
0
0
Two best talks I love to give each year: Myeloma lectures at the GW Course and MD Anderson Course for Hem Onc Trainees. I have to make it interesting enough to keep everyone’s attention for a whole hour. I learn a ton, and it’s a joy.
2
6
75
RT @sanamloghavi: For the love of God😡There has to be a better way to utilize all this fancy #AI & make @ASH_hematology abstract submission….
0
5
0
It’s not because other countries are taking advantage of us. Why then?.
Why are prescription drug prices are far higher in the US that other developed countries. I’ll break it down. A full 360. 1/ We don’t negotiate prices at launch of a new drug. Others do.
0
1
6
To apply, you need to have successfully completed accredited training in internal medicine and hematology. High-volume, complex cases + top-tier research and career mentorship. How to apply:
college.mayo.edu
1
0
4
Now Accepting Applications: Advanced Hematology Fellowship in Myeloma, amyloidosis & other plasma cell disorders @MayoClinic Rochester, MN! . 1-year, dedicated training with stipend and benefits. @MorieGertz @Rfonsi1 @MayoMyeloma.
college.mayo.edu
5
20
84
RT @MarcusVPinto: When I have a new fellow or resident in our peripheral nerve clinic, I always teach them the importance of defining the n….
0
126
0
RT @medicalwatchBC: Hi friends, it's #Myeloma Monday! Here are Top Posts of the Week 🎉🎉🎉. 1/ @VincentRK on current risk stratification of M….
0
6
0
RT @chadinabhan: ODAC voted "NO" on Blenrep for R/R multiple myeloma. Watch @VincentRK on #HUExpress sharing his thoughts on this decision….
0
7
0
RT @chadinabhan: Recently, ODAC voted "NO" on approving Blenrep 4 R/R Myeloma. In a back-to-back #HUExpress, I get @VincentRK thoughts on t….
0
4
0
RT @Larvol: 📣 𝕏 Post of the Day (July 25, 2025). Dr. Vincent Rajkumar, MD (@VincentRK) shares a key update on DREAMM-7 & DREAMM-8:. Blenr….
0
16
0
RT @mcuban: Disintermediating PBM middlemen would save Americans $100b a year says USC research. They nailed it .
academic.oup.com
Abstract. Recent concerns over rising drug prices have focused on the role of pharmacy benefit managers or PBMs. While multiple players make up the pharmac
0
454
0
RT @Mohty_EBMT: Congratulations Marivi. This is an amazing achievement. We are very proud having you as the cochair of the @COMyCongress.
0
6
0
RT @chadinabhan: This last weekend in July, spend some time W @JasmineKambojMD on #HUExpress advising Hem/Onc fellows starting training thi….
0
8
0
Why do I support approval of Belantamab? Thread.
So the belantamab ODAC is on. Personally I hope the belantamab is approved for relapsed myeloma. It has many advantages and there is a unique need for the drug in relapsed refractory myeloma. If available we will have an important option to tackle very difficult situations for.
0
0
3
Important: Belantamab (Blenrep) approved in Canada and Europe for relapsed myeloma. Belantamab is an important addition to the treatments we have. Despite the negative ODAC vote and concerns about dosing and corneal toxicity, I hope it is approved in the US as well.
0
3
9
Important: Belantamab (Blenrep) approved in Canada and Europe for relapsed myeloma. Belantamab is an important addition to the treatments we have. Despite the negative ODAC vote and concerns about dosing and corneal toxicity, I hope it is approved in the US as well.
1
14
31
RT @VincentRK: AQUILA trial showed that early intervention with daratumumab:. -Delayed progression to active myeloma.-Delayed time to needi….
0
5
0